Pathophysiological events during pregnancy influence the development of atherosclerosis in humans

Trends in Cardiovascular Medicine

Volumn 9, Issue 7, 1999, Pages 205-214

  Palinski, Wulf ^a   Napoli, Claudio ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0007914236     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(00)00022-0     Document Type: Review

References (54)

1. Aaronson SA: 1991. Growth factors and cancer. Science 254:1146-1153.
2. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ: 1989. Weight in infancy and death from ischaemic heart disease. Lancet 2:577-580.
3. Belknap WM, Dietschy JM: 1988. Sterol synthesis and low density lipoprotein clearance in vivo in the pregnant rat, placenta and fetus. Sources for tissue cholesterol during fetal development. J Clin Invest 82:2077-2085.
4. Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA: 1998. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 338:1650-1656.
5. Berliner JA, Navab M, Fogelman AM, et al.: 1995. Atherosclerosis: Basic mechanisms. Oxidation inflammation, and genetics. Circulation 91:2488-2496.
6. Breslow JL: 1996. Mouse models of atherosclerosis. Science 272:685-688.
7. Brown MS, Goldstein JL: 1999: A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci USA 96:11,041-11,048.
8. Budoff MJ, Geogiou D, Brody A, et al.: 1996. Ultrafast computed tomography as a diagnostic modality in the detection of coro-nary artery disease: A multicenter study. Circulation 93:898-904.
9. Buja LM, Kovanen PT, Bilheimer DW: 1979. Cellular pathology of homozygous familial hypercholesterolemia. Am J Pathol 97:327-357.
10. Chien KR: 1996. Genes and physiology: Molecular physiology in genetically engineered animals. J Clin Invest 98 (Suppl): S19-S26.
11. Chien KR, Grace AA: 1997. Principles of cardiovascular molecular and cellular biology. In: Braunwald E, ed. Heart Disease (5th Ed.). Philadelphia, WB Saunders, pp: 1626-1649.
12. Chien S, Li S, Shyy YJ: 1998. Effects of mechanical forces on signal transduction and gene expression in endothelial cells. Hypertension 31:162-169.
13. Cleeman JI, Grundy SM: 1997. National Cholesterol Education Program recommendations for cholesterol testing in young adults: A science-based approach. Circulation 95:1646-1650.
14. Consensus Conference: 1985. Lowering blood cholesterol to prevent coronary heart disease. JAMA 153:2080-2086.
15. Crouse JR III, Craven TE, Hagaman AP, Bond MG: 1995. Association of coronary disease with segment specific intimal-medial thickening of the extracranial carotid artery. Circulation 92:1141-1147.
16. D'Armiento FP, Di Gregorio F, Ciafrè SA, et al.: 1993. Histological findings and evidence of lipid conjugated dienes and malondialdehyde in human fetal aortas. Acta Paediatr 82:823-828.
17. Finkel T: 1998. Oxygen radicals and signaling. Curr Opin Cell Biol 10:248-253.
18. Guerci AD, Spadaro LA, Popma JJ, et al.: 1997. Relation of coronary calcium score by electron beam computed tomography to arteriographic findings in asymptomatic and symptomatic adults. Am J Cardiol 79:128-133.
19. Grundy SM, Bilheimer D, Chait A, et al.: 1993. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult-Treatment-Panel-II). JAMA 269:3015-3023.
20. Hebert PR, Gaziano JM, Chan KS, Hennekens CH: 1997. Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials. JAMA 278:313-321.
21. Hendrickse W, Stammers JP, Hull D: 1985. The transfer of free fatty acids across the human placenta. Br J Obstetr Gynaecol 92:945-952.
22. Hodis HN, Mack WJ, LaBree L, et al.: 1998. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 128:262-269.
23. Hozumi T, Yoshida K, Ogata Y, et al.: 1998. Noninvasive assessment of significant left anterior descending coronary artery stenosis by coronary flow velocity reserve with transthoracic color Doppler echocardiography. Circulation 97:1557-1562.
24. Hundley WG, Hamilton CA, Clarke GD, et al.: 1999. Visualization and functional assessment of proximal and middle left anterior descending coronary stenoses in humans with magnetic resonance imaging. Circulation 99:3248-3254.
25. Ikari Y, McManus BM, Kenyon J, Schwartz SM: 1999. Neonatal intima formation in the human coronary artery. Arterioscler Thromb Vasc Biol 19:2036-2040.
26. Ignarro LJ, Cirino G, Napoli C: 1999. Nitric oxide as a signaling molecule in the vascular system: An overview. J Cardiovasc Pharmacol 34:879-886.
27. Isaaz K, da Costa A, de Pasquale JP, Cerisier A, Lamaud M: 1998. Use of the continuity equation for transesophageal Doppler assessment of severity of proximal left coronary artery stenosis: A quantitative coronary angiography validation study. J Am Coll Cardiol 32:42-48.
28. Knopp RH: 1999. Drug treatment of lipid disorders. N Engl J Med 341:498-511.
29. Kramer MS, Joseph KS. 1996. Enigma of fetal/ infant-origins hypothesis. Lancet 348:1254-1255.
30. Libby P, Ridker PM: 1999. Novel inflammatory markers of coronary risk - Theory versus practice. Circulation 100:1148-1150.
31. McMurry MP, Connor WE, Goperud CP: 1982. The effect of dietary cholesterol upon the hypercholesterolemia of pregnancy. Metabolism 30:869-879.
32. Napoli C, D'Armiento FP, Mancini FP, Witztum JL, Palumbo G, Palinski W: 1997a. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of LDL and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest 100:2680-2690.
33. Napoli C, Ambrosio G, Scarpato N, et al.: 1997b. Decreased low-density lipoprotein oxidation after repeated selective apheresis in homozygous familial hypercholesterolemia. Am Heart J 133:585-595.
34. Napoli C, Paternò R, Faraci FM, Taguchi H, Postiglione A, Heistad DD: 1997c. Mildly oxidized low-density lipoprotein impairs responses of carotid but not basilar artery. Stroke 28:2266-2272.
35. Napoli C, Witztum JL, de Nigris F, Palumbo G, D'Armiento FP, Palinski W: 1999a. Intracranial arteries of human fetuses are more resistant to hypercholesterolemia-induced fatty streak formation than extracranial arteries. Circulation 99:2003-2010.
36. Napoli C, Salomone S, Godfraind T, et al.: 1999b. 1,4 Dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive rats. Stroke 30:1907-1915.
37. Napoli C, Glass CK, Witztum JL, Deutsch R, D'Armiento FP, Palinski W: 1999c. Influence of maternal hypercholesterolemia during pregnancy on the progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study. Lancet 354:1234-1241.
38. Napoli C, Quehenberger O, de Nigris F, Abete P, Glass CK, Palinski W: 2000. Mildly oxidized low-density lipoprotein activates multiple apoptotic signaling pathways in human coronary cells. FASEB J 15:in press.
39. National Cholesterol Education Program (NCEP): 1992. Report of the Expert Panel on blood cholesterol levels in children and adolescents. Pediatrics 89 (Suppl 3):525-570.
40. Palinski W, Hörkkö S, Miller E, et al.: 1996. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest 98:800-814.
41. Palinski W, Ord V, Plump AS, Breslow JL, Steinberg D, Witztum JL: 1994. ApoE deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehydelysine in serum. Arterioscler Thromb 14: 605-616.
42. Palinski W, Rosenfeld ME, Ylä-Herttuala S, et al.: 1989. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA 86:1372-1376.
43. Palinski W, Witztum JL: 2000. Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis. J Intern Med 247:371-380.
44. Palinski W, Ylä-Herttuala S, Rosenfeld ME, et al.: 1990. Antisera and monoclonal antibodies specific for epitopes generated during the oxidative modification of low density lipoprotein. Arteriosclerosis 10:325-335.
45. Pathobiological Determinants of Atherosclerosis in Youths (PDAY) Research Group: 1993. Natural history of aortic and coronary atherosclerotic lesions in youth. Findings from the PDAY study. Arterioscler Thromb 13:1291-1298.
46. Ricote M, Huang J, Fajas L, et al.: 1998. Expression of the peroxisome proliferator-activated receptor γ in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein. Proc Natl Acad Sci USA 95:7614-7619.
47. Ross R: 1999. Atherosclerosis - An inflammatory disease. N Engl J Med 340:115-126.
48. Rumberger JA, Simons DB, Fitzpatrick LA, Shady PF, Schwartz RS: 1995. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation 92:2157-2162.
49. Scandinavian Simvastatin Survival Study Group: 1994. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 344: 1383-1389.
50. Shepherd J, Cobbe SM, Ford I, et al.: 1995. Prevention of coronary heart disease with pravastatin in men with hypercholester-olemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 333:1301-1307.
51. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ: 1996. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347:781-786.
52. Tall A, Sharp D, Hayek T, Masucci-Magoulas L, Rubin EM, Breslow JL: 1997. Cholesteryl ester transfer protein and atherogenesis. Ann NY Acad Sci 811:178-182.
53. Witteman JC, Kannel WB, Wolf PA, et al: 1990. Aortic calcified plaques and cardiovascular disease (the Framingham Study). Am J Cardiol 66:1060-1064.
54. Witztum JL, Steinberg D: 1991. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88:1785-1792.